arrow
H

Ho-Chan Cho

korea university medicine
H指数:14
被引数:1,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial

西格列汀和恩格列净固定剂量组合作为二甲双胍的加用药物在韩国2型糖尿病患者中的疗效与安全性:一项随机、双盲、多中心、安慰剂对照、III期试验

2026-03-260
OAAI
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial
2025-12-010
OAAI
Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal Diseases

唾液类固醇谱在肾上腺疾病鉴别诊断中的临床应用价值

2025-09-010
PRE
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
2024-10-313
OAAI
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study

达格列净与格列美脲对二甲双胍控制不佳的亚洲2型糖尿病患者体成分的影响: BEYOND研究

2023-06-203
PRE